Ursa Fund Management’s Silo Pharma SILO Stock Holding History

Ursa Fund Management’s Portfolio SILO Stock Details SILO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,500	Closed	-$23.6K	–	32
2025 Q2	$23.6K	Buy	+2,500	New	+$28.6K	0.03%	31

Other funds holding SILO

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

StoneX Group New York $1.86B AUM 21.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ursa Fund Management's SILO Position: Q3 2025 in Review

Ursa Fund Management sold out of Silo Pharma (SILO) in Q3 2025, closing a stake of 2,500 shares — an estimated $23.6K sold.

Ursa Fund Management first reported a position in SILO in Q2 2025 and held it in 1 quarter. The position peaked at $23.6K in Q2 2025. 14 funds tracked by Wall St. Rank hold SILO as of Q3 2025.

Ursa Fund Management reported no remaining Silo Pharma position as of Q3 2025 after selling out during the quarter.
Ursa Fund Management sold 2,500 Silo Pharma shares in Q3 2025, an estimated $23.6K.
Ursa Fund Management first reported a position in Silo Pharma in Q2 2025 and held it in 1 quarter.
Ursa Fund Management's Silo Pharma position peaked at $23.6K in Q2 2025.
14 funds tracked by Wall St. Rank held Silo Pharma as of Q3 2025.

Based on Ursa Fund Management's 13F filing for Q3 2025, filed 14 Nov 2025.